OmniAb OABI
NASDAQ OABI
$4.47 -0.28 (-5.80%)
As of: Sep 4, 2026 · 12:49 PM EDT

OmniAb (OABI) Gross Margin (2024 - 2026)

OmniAb (OABI) posted quarterly Gross Margin of 99.9% for Q1 2026, down 3.0% year-over-year from 102.99% in Q1 2025, and little changed quarter-over-quarter from 99.89% in Q4 2025.

Analysis

OmniAb (OABI) Gross Margin (2024 - 2026) Analysis & Trends

OmniAb (OABI) has reported Gross Margin for 3 consecutive years, with 99.9% the latest figure, recorded in Q1 2026.

  • In Q1 2026, Gross Margin fell 3.0% year-over-year to 99.9%; the TTM figure through Mar 2026 stood at 98.91% (down 108.0% YoY), while the FY2025 annual figure was 98.38%, down 162.0% from the prior year.
  • Gross Margin was little changed at 99.9% in Q1 2026 per OABI's latest filing, from 99.89% in the prior quarter.
  • Across five years, Gross Margin topped out at 100.0% in Q2 2024 and bottomed at 93.28% in Q2 2025.
  • Historically, Gross Margin has averaged 98.96% across 3 years, with a median of 99.91% in 2025.
  • Annual changes were most pronounced in 2025 — Gross Margin plunged 672 bps — and 2026, when it declined 3 bps.
  • OmniAb's Gross Margin stood at 100.0% in 2024, then retreated by 0 bps to 99.89% in 2025, then rose by 0 bps to 99.9% in 2026.
  • Business Quant data shows OABI's Gross Margin at 99.9% in Q1 2026, 99.89% in Q4 2025, and 98.7% in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Vertex Pharmaceuticals 139.62 Bn 131.77 Bn 2.84 Bn 85.33%
2 Regeneron Pharmaceuticals 85.73 Bn 77.73 Bn 3.93 Bn 91.59%
3 Argenx Se 63.53 Bn 58.35 Bn 1.37 Bn 90.43%
4 Moderna 58.23 Bn 53.09 Bn 52.00 Mn 35.86%
5 Revolution Medicines 44.05 Bn 44.05 Bn - -
6 BeOne Medicines 40.03 Bn 34.93 Bn 1.53 Bn 89.76%
7 Alnylam Pharmaceuticals 35.50 Bn 32.19 Bn 992.69 Mn 76.90%
8 Royalty Pharma 28.52 Bn 27.68 Bn - -
9 Insmed 27.46 Bn 26.30 Bn 358.27 Mn 84.20%
10 OmniAb 576.36 Mn 524.36 Mn 12.81 Mn 95.45%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 95.45%
Mar 31, 2026 99.90%
Dec 31, 2025 99.89%
Sep 30, 2025 98.70%
Jun 30, 2025 93.28%
Mar 31, 2025 99.93%
Dec 31, 2024 100.00%
Sep 30, 2024 100.00%
Jun 30, 2024 100.00%